Experiments with mice suggest a potential early treatment to avoid a deadly infection.
A new study examines how a household remedy—baking soda—could help patients with diabetic ketoacidosis (DKA) avoid death from a fungal infection that affects them at higher rates than healthy patients.
The study, published in the Journal of Clinical Investigation, found that sodium bicarbonate reversed the physical effects that allow the spread of mucomycosis, an infection that can occur alongside DKA in persons with diabetes.
DKA happens when insulin levels drop to levels that the body can no longer use glucose as fuel, and the body instead uses fat, causing poisonous acids called ketones to accumulate in the body. In the worst cases, DKA can lead to diabetic coma or death.
One process that occurs in DKA is the infection mucormycosis. Researchers reporting in the journal identified the processes that promote the infection and inhibit the work of cells called phagocytes, which help the body destroy invading microorganisms. In experiments with mice, they learned that DKA indirectly allows for a release of iron from transferrin, which in turn speeds the infection. Thus, they write, early use of sodium bicarbonate and iron chelation would help prevent these effects.
“The current guidelines for correcting acidosis of DKA doesn’t indicate using sodium bicarbonate until the acidosis is severe,” said Ashraf S. Ibrahim, PhD, an LA Biomed researcher and author of the study. “Our data strongly suggest that DKA patients suspected of having mucomycosis would benefit from adding sodium bicarbonate to the treatment regimen—regardless of whether they have severe acidosis or not—because sodium bicarbonate is likely to halt the growth of the fungus.”
The authors said more work is needed through well-designed clinical trials involving patients with DKA and mucomycosis infections.
Reference
Gebremariam T, Lin L, Liu M, et al. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and allecviates mucormycosis [published May 9, 2016]. J Clin Invest. 2016; doi:10.1172/JCI82744
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout
February 22nd 2024More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Read More
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More